| ID | Sequence | Length | GC content |
|---|---|---|---|
| GCGCUGCGGCCGCCCGCGCGGACCCGGCGAGAGGCGGCGGCGGGAGCGG… | 844 nt | 0.6102 | |
| GCGCUGCGGCCGCCCGCGCGGACCCGGCGAGAGGCGGCGGCGGGAGCGG… | 1360 nt | 0.6007 | |
| GCGCUGCGGCCGCCCGCGCGGACCCGGCGAGAGGCGGCGGCGGGAGCGG… | 1213 nt | 0.5977 | |
| GCGCUGCGGCCGCCCGCGCGGACCCGGCGAGAGGCGGCGGCGGGAGCGG… | 596 nt | 0.6040 | |
| GCGCUGCGGCCGCCCGCGCGGACCCGGCGAGAGGCGGCGGCGGGAGCGG… | 1412 nt | 0.6006 | |
| GCGCUGCGGCCGCCCGCGCGGACCCGGCGAGAGGCGGCGGCGGGAGCGG… | 795 nt | 0.6075 | |
| GCGCUGCGGCCGCCCGCGCGGACCCGGCGAGAGGCGGCGGCGGGAGCGG… | 648 nt | 0.6034 | |
| GCGCUGCGGCCGCCCGCGCGGACCCGGCGAGAGGCGGCGGCGGGAGCGG… | 756 nt | 0.6045 |
The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein forms a heterodimer with BCL2, and functions as an apoptotic activator. The association and the ratio of BAX to BCL2 also determines survival or death of a cell following an apoptotic stimulus. This protein is reported to interact with, and increase the opening of, the mitochondrial voltage-dependent anion channel (VDAC), which leads to the loss in membrane potential and the release of cytochrome c. The expression of this gene is regulated by the tumor suppressor P53 and has been shown to be involved in P53-mediated apoptosis. Multiple alternatively spliced transcript variants, which encode different isoforms, have been reported for this gene. [provided by RefSeq, Dec 2019] CIViC Summary for BAX Gene
A study in mice demonstrated that the protein expression of the BAX in postmortem skin peaked at 8–12 hours after death and then gradually decreased, while its mRNA expression showed a prominent change at 4 hours [Xie et al. DOI:10.1007/S12024-023-00757-5]. These statistically significant, time-dependent changes in the BAX's protein and mRNA levels indicate its potential application for estimating the early postmortem interval. A study in human cell cultures demonstrated that serum from polytraumatised patients significantly decreased apoptosis of human bone-marrow stromal cells compared to control serum, an effect associated with an inhibition of the BAX mRNA expression [Eid et al. DOI:10.1302/0301-620X.88B10.17139].